← Back to Search

Default Option for Skilled Nursing Facilities

N/A
Waitlist Available
Led By Amir Goren, PhD
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months or as long as it takes to reach n=5,000, whichever occurs first
Awards & highlights

Study Summary

This trial is testing whether displaying preferred nursing homes first in the Repisodic app will increase the number of patients who choose those homes and decrease their length of stay. They're also testing whether a short video about the benefits of care coordination in nursing homes will increase the number of patients who choose to transfer to one.

Eligible Conditions
  • Skilled Nursing Facilities
  • Behavioral Economics

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months or as long as it takes to reach n=5,000, whichever occurs first
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months or as long as it takes to reach n=5,000, whichever occurs first for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
LoS (patient/caretaker level)
Overall LoS (system/case manager level)
P-SNF percent selected (case manager level)
+5 more
Secondary outcome measures
Time to pre-select a SNF (case manager level)
Time to select a SNF (patient/caretaker level)
Other outcome measures
LoS for patients who had a P-SNF as an option (patient/caretaker level)
P-SNF placement for patients who had a P-SNF as an option (patient/caretaker level)
P-SNF selection for patients who had a P-SNF as an option (patient/caretaker level)

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: P-SNF Top-Sorted List (case manager level)Experimental Treatment1 Intervention
This condition is the same as the Default List, except that relevant providers (i.e., those meeting patient needs and located within a threshold distance to be determined per hospital) who are part of the Geisinger preferred provider network will be presented at the top of the otherwise ranked list of SNFs. Situations in which there are no relevant P-SNFs will be flagged yet still assigned to this condition, in an intent-to-treat analysis; the default algorithm-based rank-ordered approach will be applied to all non-preferred providers.
Group II: P-SNF List/P-SNF Map/P-SNF Video (patient level)Experimental Treatment1 Intervention
This is the same as the Full List condition, except that both the list and the map will present only the P-SNFs, with a button allowing patients to view all results only if they opt to do so. Moreover, the link to viewing the optional introductory video will be highlighted, and the video will include sections describing the advantage of P-SNFs for care coordination. When only a paper printout is available, the same SNF sorting order will be presented on paper, with only the P-SNFs presented on the first page.
Group III: Default List (case manager level)Active Control1 Intervention
In this condition, all SNF options will be presented to case managers in Repisodic in rank order according to Repisodic's algorithm that weights dimensions such as Centers for Medicare & Medicaid Services (CMS) quality metric ratings, distance, and the match between SNF features and specific patient need. The list only includes SNFs that accept the patient's insurance.
Group IV: Full List/Full Map/Default Video (patient level)Active Control1 Intervention
All SNF options, both P-SNFs and NP-SNFs (up to a maximum of 10 by default) that case managers preselected for patients will be presented to patients in rank order (according to Repisodic's algorithm, as described above). Patients will also have the option of viewing the default Repisodic map, which will show the SNFs on the list, and patients will be provided the link to an introductory video presenting the SNF selection and discharge process. When only a paper printout is available, the same SNF sorting order will be presented on paper.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Order of Options
2021
N/A
~5590
Default Option
2018
N/A
~5620

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor
148 Previous Clinical Trials
1,880,512 Total Patients Enrolled
Amir Goren, PhDPrincipal InvestigatorGeisinger Clinic
20 Previous Clinical Trials
526,140 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for volunteers in this clinical trial?

"According to the clinicaltrials.gov page, this study is no longer actively seeking participants; it was first posted on May 28th 2021 and last updated on December 2nd 2022. However, there are 4 other medical trials that still need volunteers."

Answered by AI
~1456 spots leftby Apr 2025